Jimpei Miyakawa

About

Jimpei Miyakawa is a urologic surgeon and researcher whose work focuses on improving surgical outcomes and treatment decision-making for prostate cancer. He is best known for developing the “prostate-muscle index” (PMI), a novel pelvic cavity measurement that predicts blood loss and console time during robot-assisted radical prostatectomy (RARP)—a contribution that has earned 10 citations and offers a practical tool for preoperative planning. Miyakawa has also made significant strides in health economics, comparing medical costs of active surveillance versus aggressive treatments for early prostate cancer using data from the PRIAS-JAPAN study (8 citations), providing crucial evidence for cost-effective care. Additionally, his investigation into uroflowmetry parameters and lower urinary tract symptoms following RARP (7 citations) helps clinicians better manage post-surgical quality of life. Through these studies, Miyakawa bridges surgical technique, patient-reported outcomes, and economic analysis, offering a comprehensive view of prostate cancer management. His work is particularly valuable for researchers and clinicians seeking to optimize both clinical results and healthcare resource allocation in urologic oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   The ‘prostate-muscle index’: a simple pelvic cavity measurement predicting estimated blood loss and console time in robot-assisted radical prostatectomy

   10 citations · 2022
2. 2
   Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS‐JAPAN study

   8 citations · 2022
3. 3
   The association between the parameters of uroflowmetry and lower urinary tract symptoms in prostate cancer patients after robot-assisted radical prostatectomy

   7 citations · 2022

Key Collaborators

Contact & Links